Skip to content

The comparative study of effect of aerial parts of Stachys lavandulifolia and Medroxyprogestrone drug in symptomatic treatment of polycystic ovarian syndrome

The comparative study of effect of aerial parts of Stachys lavandulifolia and Medroxyprogestrone drug in symptomatic treatment of polycystic ovarian syndrome

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT138903013922N1
Enrollment
66
Registered
2010-05-22
Start date
2010-05-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polycystic ovarian syndrome. Polycystic ovarian syndrome

Interventions

Intervention 1: 5g of Stachys lavandulifolia as infusion three time a day for 3 month. Intervention 2: 10mg of Medroxyprogestron per day for 10 days in a menstruation cycle for 3 cycles.
Treatment - Drugs
5g of Stachys lavandulifolia as infusion three time a day for 3 month
10mg of Medroxyprogestron per day for 10 days in a menstruation cycle for 3 cycles

Sponsors

Kermanshah University of medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Inclusion criteria: 1- with polycystic ovarian syndrome 2- with abnormal uterine bleeding 3- sonographic appearance. Exclusion criteria: 1- lack of cooperation.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Ovarian cysts. Timepoint: 3 month. Method of measurement: sonographic survey.;Mensturation bleeding disorder. Timepoint: 3 month. Method of measurement: questionnaire.

Secondary

MeasureTime frame
Side effects. Timepoint: 3 month. Method of measurement: questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Masoud Modarreri

Faculty of Pharmacy - Kermanshah University of medical Sciences

mmodarresi@kums.ac.ir , modarresi1262@yahoo.com+98 83 1427 6482

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026